Neuroinflammation: A Therapeutic Target of Cotinine for the Treatment of Psychiatric Disorders?

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|22|10|1324-1333

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.22, Iss.10, 2016-03, pp. : 1324-1333

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuroinflammation: a potential therapeutic target

By Craft Jeffrey M   Watterson D Martin   Van Eldik Linda J  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 887-900

Informa Healthcare

Access to resources Recommend Favorite

The Dopamine D3 Receptor: A Therapeutic Target for the Treatment of Neuropsychiatric Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 1, 2006-02 ,pp. : 25-43

Bentham Science Publishers

Access to resources Recommend Favorite

Synaptic Plasticity as a Therapeutic Target in the Treatment of Autism-related Single-gene Disorders

By  

Current Pharmaceutical Design, Vol. 19, Iss. 36, 2013-11 ,pp. : 6480-6490

Bentham Science Publishers

Access to resources Recommend Favorite

The GABA Shunt: An Attractive and Potential Therapeutic Target in the Treatment of Epileptic Disorders

By  

Current Drug Metabolism, Vol. 6, Iss. 2, 2005-04 ,pp. : 127-139

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue: Neuroinflammation a Common Link in Neurodegenerative Neurological and Psychiatric Disorders)

By  

Current Pharmaceutical Design, Vol. 22, Iss. 10, 2016-03 ,pp. : 1293-1293

Bentham Science Publishers

Access to resources Recommend Favorite